NCT04756349

Brief Summary

The objective of this randomized, double-blind clinical trial is to evaluate the clinical performance of non-carious cervicals adhesive restorations using three self-etching adhesives containing HEMA and 10-MDP monomers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 12, 2020

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

February 5, 2021

Completed
7 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 12, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 16, 2021

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 12, 2022

Completed
Last Updated

May 24, 2022

Status Verified

May 1, 2022

Enrollment Period

1 year

First QC Date

February 5, 2021

Last Update Submit

May 17, 2022

Conditions

Keywords

adhesivesdental bonding

Outcome Measures

Primary Outcomes (2)

  • Retention rate of restoration

    The retention rate will be assessed following the USPHS (United States Public Health) guidelines with the following classifications (acronyms): Alpha = retained. Charlie = mobility or loss.

    01 year

  • Retention rate of restoration

    The retention rate will be assessed following the USPHS (United States Public Health) guidelines with the following classifications (acronyms): Alpha = retained. Charlie = mobility or loss.

    02 years

Secondary Outcomes (4)

  • Marginal staining rate of restoration

    01 year

  • Marginal staining rate of restoration

    02 years

  • Marginal Adaptation rate of restoration

    01 year

  • Marginal Adaptation rate of restoration

    02 years

Other Outcomes (4)

  • Postoperative sensitivity rate of restoration

    01 year

  • Postoperative sensitivity rate of restoration

    02 years

  • Secondary caries rate of restoration

    01 year

  • +1 more other outcomes

Study Arms (3)

Clearfil SE

ACTIVE COMPARATOR

Group containing 10-MDP and HEMA monomers

Other: composite resin restoration

Optibond All-in-One

ACTIVE COMPARATOR

Group containing HEMA monomer

Other: composite resin restoration

Prime & Bond Universal

ACTIVE COMPARATOR

Control Group containing other monomers

Other: composite resin restoration

Interventions

All patients will receive adhesive composite resin restorations. There will be 3 groups (different adhesives): Clearfil SE, Optibond All-in-One and Prime \& Bond Universal.

Also known as: composite resin restorations with Clearfil SE adhesive, composite resin restorations with Optibond All-in-One adhesive, composite resin restorations with Prime & Bond Universal adhesive
Clearfil SEOptibond All-in-OnePrime & Bond Universal

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Good oral hygiene
  • Absence of periodontal disease
  • Presence of at least 02 non-carious cervical lesions

You may not qualify if:

  • Presence of non-carious cervical lesion in non-vital teeth
  • Occlusal instability
  • Presence of orthodontic appliance
  • Presence of removable partial dental prosthesis
  • High risk of caries (presence of three or more active caries lesions)
  • Xerostomia
  • Bruxism
  • Patients allergic to base materials monomers
  • Patients who do not accept the project conditions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Para's Federal University

Belém, Pará, 66075-110, Brazil

Location

MeSH Terms

Interventions

PRIME protocol

Study Officials

  • Roberta Oliveira, Msc

    Federal University of Pará

    PRINCIPAL INVESTIGATOR
  • Brennda De Paula, Msc

    Federal University of Pará

    STUDY CHAIR
  • Cecy Silva, PhD

    Federal University of Pará

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical professor

Study Record Dates

First Submitted

February 5, 2021

First Posted

February 16, 2021

Study Start

February 12, 2020

Primary Completion

February 12, 2021

Study Completion

February 12, 2022

Last Updated

May 24, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations